Hepatic encephalopathy: pathophysiology and emerging therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19577116.
- Also identified by DOI 10.1016/j.mcna.2009.03.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hepatic encephalopathy is characterized by neuropsychiatric abnormalities in patients with liver failure. Severe hepatic encephalopathy is an indication for liver transplantation as it portends poor outcome. Treatment of hepatic encephalopathy involves correction of precipitating factors such as sepsis, gastrointestinal bleeding, medications, and electrolyte imbalance. Effective therapies include lactulose and antibiotics such as neomycin, metronidazole, and rifaximin.
Medical subject headings
- Hepatic Encephalopathy